ODTX
ODTX
US67613T1043
Odyssey Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
913.11M EUR
898.67M EUR
Enterprise Value
582.53M EUR
841.46M EUR
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-4.36x
--
Price to Sales
9,223.35x
312.36x
Price to Book
2.16x
2.13x
EV/Revenue
5,884.17x
292.48x
EV/EBITDA
-3.88x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
-16.66%
ende